Financial Summary (All financials)
| In millions, except per share items | Aug-31-16 | Aug-31-15 | Aug-31-14 | Aug-31-13 | Aug-31-12 | Aug-31-11 | Aug-31-10 | Aug-31-09 |
| Revenues | 2,101.9 | 2,566.3 | 2,996.9 | 3,613.9 | 4,193.2 | 4,711.0 | 4,906.6 | 3,953.6 |
| Revenue growth | -18.1% | -14.4% | -17.1% | -13.8% | -11.0% | -4.0% | 24.1% | 26.2% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1,922.8 |
| Gross profit | 2,101.9 | 2,566.3 | 2,996.9 | 3,613.9 | 4,193.2 | 4,711.0 | 4,906.6 | 2,030.7 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 51.4% |
| Sales and marketing | 354.8 | 487.8 | 545.6 | 629.9 | 641.7 | 654.4 | 622.8 | 497.6 |
| General and administrative | 246.2 | 273.7 | 286.2 | 325.1 | 341.9 | 355.5 | 301.1 | 277.9 |
| EBITA | 101.2 | 211.0 | 452.4 | 657.0 | 752.1 | 1,213.4 | 1,218.1 | 1,146.4 |
| EBITA margin | 4.8% | 8.2% | 15.1% | 18.2% | 17.9% | 25.8% | 24.8% | 29.0% |
| Amortization of intangibles | 14.3 | 14.2 | 12.1 | 4.0 | 20.2 | 14.7 | 24.8 | |
| EBIT | 86.9 | 196.8 | 440.3 | 653.0 | 731.9 | 1,198.7 | 1,193.3 | 1,146.4 |
| EBIT margin | 4.1% | 7.7% | 14.7% | 18.1% | 17.5% | 25.4% | 24.3% | 29.0% |
| Pre-tax income | -71.5 | 105.6 | 348.7 | 451.6 | 666.3 | 948.2 | 999.1 | 1,066.9 |
| Income taxes | 9.8 | 58.2 | 127.3 | 184.1 | 282.8 | 419.1 | 463.6 | 456.7 |
| Tax rate | | 55.1% | 36.5% | 40.8% | 42.4% | 44.2% | 46.4% | 42.8% |
| Earnings from continuing ops | -74.9 | 100.4 | 447.4 | 534.5 | 389.2 | 565.7 | 1,102.4 | 610.2 |
| Earnings from discontinued ops | -9.7 | -23.2 | -16.6 | -18.5 | 33.5 | 6.7 | -13.9 | -16.4 |
| Net income | -84.6 | 77.2 | 430.7 | 516.0 | 422.7 | 572.4 | 1,088.5 | 593.8 |
| Net margin | -4.0% | 3.0% | 14.4% | 14.3% | 10.1% | 12.2% | 22.2% | 15.0% |
| |
| Diluted EPS | ($0.69) | $0.92 | $3.97 | $4.72 | $3.18 | $3.99 | $7.21 | $3.83 |
| Shares outstanding (diluted) | 108.7 | 109.0 | 112.6 | 113.3 | 122.4 | 141.8 | 152.9 | 159.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|